Methylenedioxybenzylamphetamine
Names | |
---|---|
IUPAC name
1-(1,3-benzodioxol-5-yl)-N-benzylpropan-2-amine | |
Identifiers | |
65033-29-6 | |
3D model (Jmol) | Interactive image |
UNII | QR8242661A |
| |
Properties | |
C17H19NO2 | |
Molar mass | 269.343 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
MDBZ, or 3,4-methylenedioxy-N-benzylamphetamine, is a lesser-known psychedelic drug. It is the N-benzyl derivative of MDA. MDBZ was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 150 mg, and the duration unknown. MDBZ produces few to no effects. Very few data exist about the pharmacological properties, metabolism, and toxicity of MDBZ.
In an episode of the British spoof documentary TV show Brass Eye, David Amess MP was fooled into recording a warning against a fictitious new drug called "cake". When asked a parliamentary question about it, the Home Office incorrectly assumed Amess was referring to 3,4-methylenedioxy-N-benzylamphetamine.[1]
See also
References
External links
This article is issued from Wikipedia - version of the 10/6/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.